Unichem Labs will get USFDA nod to market generic antidepressant tablets


Drug agency Unichem Laboratories on Thursday mentioned it has acquired approval from the US well being regulator to market generic Amitriptyline HCl tablets used within the therapy of melancholy.

The corporate has acquired abbreviated new drug utility (ANDA) approval to market its Amitriptyline HCl tablets USP, within the strengths of 10 mg, 25 mg, 50 mg, 75 mg, 100 mg and 150 mg from the US Meals and Drug Administration (USFDA), Unichem Laboratories mentioned in a regulatory submitting.

The product is a generic model of AstraZeneca Prescription drugs LP’s Elavil tablets in the identical strengths, it added.

The tablets might be commercialised from the corporate’s Goa plant, mentioned.

Amitriptyline HCl Tablets are indicated for the reduction of signs of melancholy, it added.

Shares of Unichem Laboratories closed at Rs 358.60 per scrip on BSE, up 7.43 per cent from its earlier shut.

(Solely the headline and movie of this report might have been reworked by the Enterprise Commonplace workers; the remainder of the content material is auto-generated from a syndicated feed.)

Expensive Reader,

Enterprise Commonplace has all the time strived arduous to offer up-to-date data and commentary on developments which are of curiosity to you and have wider political and financial implications for the nation and the world. Your encouragement and fixed suggestions on find out how to enhance our providing have solely made our resolve and dedication to those beliefs stronger. Even throughout these tough instances arising out of Covid-19, we proceed to stay dedicated to conserving you knowledgeable and up to date with credible information, authoritative views and incisive commentary on topical problems with relevance.

We, nonetheless, have a request.

As we battle the financial affect of the pandemic, we want your assist much more, in order that we are able to proceed to give you extra high quality content material. Our subscription mannequin has seen an encouraging response from a lot of you, who’ve subscribed to our on-line content material. Extra subscription to our on-line content material can solely assist us obtain the targets of providing you even higher and extra related content material. We imagine in free, truthful and credible journalism. Your assist by means of extra subscriptions may also help us practise the journalism to which we’re dedicated.

Help high quality journalism and subscribe to Business Standard.

Digital Editor

Source link


Please enter your comment!
Please enter your name here